title: A novel function of Ataxin-1 in the modulation of PP2A activity is dysregulated in the spinocerebellar ataxia type 1.
abstract: An expansion of glutamines within the human ataxin-1 protein underlies spinocerebellar ataxia type 1 (SCA1), a dominantly inherited neurodegenerative disorder characterized by ataxia and loss of cerebellar Purkinje neurons. Although the mechanisms linking the mutation to the disease remain unclear, evidence indicates that it involves a combination of both gain and loss of functions of ataxin-1. We previously showed that the mutant ataxin-1 interacts with Anp32a, a potent and selective PP2A inhibitor, suggesting a role of PP2A in SCA1. Herein, we found a new function of ataxin-1: the modulation of Pp2a activity and the regulation of its holoenzyme composition, with the polyglutamine mutation within Atxn1 altering this function in the SCA1 mouse cerebellum before disease onset. We show that ataxin-1 enhances Pp2a-bβ expression and down-regulates Anp32a levels without affecting post-translational modifications of Pp2a catalytic subunit (Pp2a-c) known to regulate Pp2a activity. In contrast, mutant Atxn1 induces a decrease in Y307-phosphorylation in Pp2a-c, known to enhance its activity, while reducing Pp2a-b expression and inhibiting Anp32a levels. qRT-PCR and chromatin immunoprecipitation analyses show that ataxin-1-mediated regulations of the Pp2a-bβ subunit, specifically bβ2, and of Anp32a occur at the transcriptional level. The Pp2a pathway alterations were confirmed by identified phosphorylation changes of the known Pp2a-substrates, Erk2 and Gsk3β. Similarly, mutant ataxin-1-expressing SH-SY5Y cells exhibit abnormal neuritic morphology, decreased levels of both PP2A-Bβ and ANP32A, and PP2A pathway alterations, all of which are ameliorated by overexpressing ANP32A. Our results point to dysregulation of this newly assigned function of ataxin-1 in SCA1 uncovering new potential targets for therapy.
authors: Basic, Translational and Molecular Neurogenetics Research Unit in Neurosciences, Health Sciences Research Institute Germans Trias y Pujol (IGTP), Badalona, Barcelona, Spain.
authors: Ivelisse
authors: I
authors: Sánchez
authors: Patricia
authors: P
authors: Piñol
authors: Marc
authors: M
authors: Corral-Juan
authors: Massimo
authors: M
authors: Pandolfo
authors: Antoni
authors: A
authors: Matilla-Dueñas
mesh_terms: D000818:Animals; D000067696:Ataxin-1; D000067528:Ataxins; D002478:Cells, Cultured; D002531:Cerebellum / Q000378:metabolism* / Q000503:physiopathology; D038362:Glycogen Synthase Kinase 3 / Q000378:metabolism; D000071679:Glycogen Synthase Kinase 3 beta; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D009419:Nerve Tissue Proteins / Q000235:genetics* / Q000378:metabolism*; D016501:Neurites / Q000648:ultrastructure; D009687:Nuclear Proteins / Q000235:genetics* / Q000378:metabolism*; D010766:Phosphorylation; D054648:Protein Phosphatase 2 / Q000378:metabolism*; D016601:RNA-Binding Proteins; D017448:Receptors, Dopamine D2 / Q000378:metabolism; D015398:Signal Transduction; D020754:Spinocerebellar Ataxias / Q000235:genetics* / Q000378:metabolism* / Q000503:physiopathology
chemical_list: C000593749:ATXN1 protein, human; C530107:Anp32a protein, mouse; D000067696:Ataxin-1; D000067528:Ataxins; C000593750:Atxn1 protein, mouse; D009419:Nerve Tissue Proteins; D009687:Nuclear Proteins; D016601:RNA-Binding Proteins; D017448:Receptors, Dopamine D2; C000605506:GSK3B protein, human; D000071679:Glycogen Synthase Kinase 3 beta; C000605507:Gsk3b protein, mouse; D038362:Glycogen Synthase Kinase 3; D054648:Protein Phosphatase 2
references: Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):6957-62
references: 21482799
references: Biochem Biophys Res Commun. 2004 Mar 12;315(3):568-74
references: 14975738
references: J Neurochem. 2010 Aug;114(3):706-16
references: 20477910
references: Cerebellum. 2005;4(1):7-18
references: 15895553
references: Nat Rev Mol Cell Biol. 2006 May;7(5):359-71
references: 16633338
references: Nature. 2008 Apr 10;452(7188):713-8
references: 18337722
references: J Comp Neurol. 1998 Mar 23;392(4):515-27
references: 9514514
references: J Cell Biol. 2012 Apr 16;197(2):167-77
references: 22508507
references: Nat Med. 2011 Oct 16;17(11):1445-7
references: 22001907
references: J Biol Chem. 2011 Oct 7;286(40):34606-16
references: 21835928
references: J Neurosci. 1998 Jul 15;18(14):5508-16
references: 9651231
references: Nature. 1997 Oct 30;389(6654):974-8
references: 9353121
references: Neurobiol Dis. 2012 Dec;48(3):526-32
references: 22884877
references: J Neurosci. 1997 Oct 1;17(19):7385-95
references: 9295384
references: Exp Cell Res. 2008 Jan 1;314(1):68-81
references: 17803990
references: Bioinformatics. 2007 Nov 1;23(21):2947-8
references: 17846036
references: J Neurochem. 2001 Aug;78(3):468-81
references: 11483649
references: J Biol Chem. 2007 Sep 14;282(37):26971-26980
references: 17635907
references: Cell. 1995 Sep 22;82(6):937-48
references: 7553854
references: J Biol Chem. 2010 Mar 19;285(12):8515-26
references: 20097758
references: Enzyme Res. 2011;2011:398751
references: 21755039
references: Cell. 2003 May 16;113(4):457-68
references: 12757707
references: Biochemistry. 1995 Feb 14;34(6):1988-96
references: 7531497
references: J Biol Chem. 2008 Apr 18;283(16):10513-21
references: 18245083
references: Cerebellum. 2008;7(2):106-14
references: 18418661
references: J Alzheimers Dis. 1999 Dec;1(6):361-378
references: 12214113
references: Nat Genet. 1993 Jul;4(3):221-6
references: 8358429
references: Front Mol Neurosci. 2011 Nov 23;4:48
references: 22131966
references: Trends Biochem Sci. 2008 Mar;33(3):113-21
references: 18291659
references: Cerebellum. 2010 Jun;9(2):148-66
references: 19890685
references: PLoS Genet. 2010 Jul 08;6(7):e1001021
references: 20628574
references: Handb Clin Neurol. 2012;103:535-47
references: 21827912
references: Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4221-6
references: 11904383
references: Hum Mol Genet. 2004 Oct 15;13(20):2535-43
references: 15317756
references: Hum Mol Genet. 2007 Sep 1;16(17):2122-34
references: 17599952
references: EMBO Rep. 2011 May;12(5):428-35
references: 21475249
references: J Biol Chem. 2003 Sep 5;278(36):34691-9
references: 12807913
references: Hum Mol Genet. 2001 Jan 1;10(1):25-30
references: 11136710
references: Am J Pathol. 2003 Sep;163(3):833-43
references: 12937125
references: Eur J Neurosci. 2002 Dec;16(11):2039-48
references: 12473071
references: Methods. 2001 Dec;25(4):402-8
references: 11846609
references: Int J Dev Neurosci. 2006 Nov;24(7):437-43
references: 17045446
references: PLoS Med. 2007 May;4(5):e182
references: 17535104
references: EMBO J. 2006 Feb 22;25(4):727-38
references: 16456541
references: Neuron. 2003 May 8;38(3):375-87
references: 12741986
references: Mol Cell Biol. 2009 Feb;29(3):662-74
references: 19029245
references: FEBS Lett. 2007 Feb 20;581(4):617-22
references: 17266954
references: Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2979-84
references: 17301223
references: Hum Genet. 2010 Aug;128(2):205-12
references: 20533062
references: J Biol Chem. 2008 Dec 26;283(52):36241-8
references: 18940801
references: FEBS J. 2008 May;275(10):2548-60
references: 18410380
references: Nature. 2003 Jan 23;421(6921):373-9
references: 12540902